'Support Egypt' coalition to submit Senate draft law, amendments to House of Representatives law on Sunday    Egypt assigns EGP 36.7bn for 691 green projects in FY 2020/21    Egypt's confirms total COVID-19 cases up to 32612, with 1198 deaths    Egyptian expats narrate their stories of loneliness during pandemic    COVID-19 made death of loved ones crueller and more painful    Culture Ministry to present virtual theatre performances on YouTube    Raya Foods anticipates 20% growth in upcoming 5 years    ACUD to support developers in New Capital with flexible payment systems    Recent devaluation of Egyptian pound against US dollar normal, temporary: banking pundit    Tourism Minister prepares for gradual return of activities    Clashes, tear gas in Beirut as protests turn to riots    OPEC and allies reportedly agree to extend record production cut    Brazil Bolsonaro threatens to pull out of WHO as coronavirus    Iranian wedding party fuelled new coronavirus surge: Rouhani    Zimbabwe grain deficit seen widening to 1.17 mln tonnes    Investigations under way as a large fire destroys Amazon Distribution Warehouse in Southern California    India overtakes Italy's coronavirus passes as lockdown easing looms    North Korea threatens to permanently shut liaison office with South    Al-Sisi announces Cairo Declaration to end Libyan conflict    Egyptian state banks collect over $10 bln from high-yield savings product    Paris gallery seeks inspiration in ancient China's hats to enforce social distancing    US officials block police 'extreme tactics' as protests enter 12th day    Italian federation agrees to allow five substitutions in Serie A    Solskjaer talks up Manchester United mentality ahead of Tottenham match    Friday's prayer to be held at Cairo's Al-Hussein Mosque next week    Michael Jordan giving $100 million for racial equality, justice    Egypt Purchasing Managers Index increases 37% in May-Planning Ministry    Egypt, Belgium stress importance of bolstering bilateral ties    Jordan reopens mosques for socially distanced prayers    Dortmund's Sancho, Akanji fined for getting haircuts without face masks    Moroccan actor Youssef Kerkour scoops BAFTA nomination    Cairo Airport Museum receives artifacts ahead of planned opening    US prosecutors charge 3 more police officers over George Floyd killing    CAF draws timeline for resumed continental championships amid COVID-19    Egyptian Football star Ahmed Fathy's wife, daughters infected with Coronavirus    TSFE to develop, operate Bab Al-Azab historical area    Misusing the Nile    Sudan urges UN Security Council to encourage GERD parties to refrain from 'unilateral measures'    Egypt's Zamalek close to signing Angola's Papel in summer    We Are One: Global film festival launches amid pandemic    Zamalek re-hang ‘Real Club of the Century' billboard after removing CAF logo    Armed Forces neutralise 19 militants in North Sinai operations    Farwell to 89-year old Egyptian actor Hassan Hosny    Ethiopia says it won't accept Egypt's ‘historic rights' to Nile water    Egypt removes 484 illegal constructions and encroachments on Nile    Salah did not pressure administration to include players on team: Ghazal    Sisi congratulates Egyptians on occasion of Eid Al-Fitr    Egypt's 12 MPs came into contact with coronavirus infected parliamentarian    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Novartis: it's ‘too soon' to know whether malaria drug could be coronavirus vaccine
Published in Amwal Al Ghad on 27 - 03 - 2020

Swiss pharma giant Novartis on Friday has cautioned that it is "too soon" to be sure whether two anti-malaria drugs could be the definitive vaccine for the coronavirus.
Novartis is one of the main producers of one of the two anti-malaria drugs, hydroxychloroquine.
Trump touted at a White House press briefing last week the two anti-malaria drugs as a "game-changer" in the global fight against the coronavirus pandemic, noting that they had shown "very, very encouraging results.″
Chloroquine is a decades-old drug that was approved by the Food and Drug Administration (FDA) in 1949 as a treatment for malaria. Its derivative, hydroxychloroquine, is normally used by doctors as a treatment for rheumatoid arthritis and lupus.
"With hydroxychloroquine, what we know is in pre-clinical studies, the drug is quite active against the coronavirus but these are, of course, not in human beings — not in patients," Vas Narasimhan, chief executive of Novartis, has told CNBC's "Squawk Box Europe" via video link on Friday.
"I do think it is too soon to know for sure until we have properly controlled randomised studies," Narasimhan said.
"We hope over the next 18 months to two years, we can come back with a vaccine that will ultimately be the definitive way to deal with this pandemic."
As of Friday, over 537,000 people across the world had contracted the coronavirus according to data compiled by Johns Hopkins University, with 24,110 deaths.
To date, there are no vaccines or treatments available for the flu-like virus. However, trials are underway to find drugs that could serve this purpose.
One of those trials are led by the University of Minnesota as it will test to see whether hydroxychloroquine can prevent or reduce the severity of the coronavirus.


Clic here to read the story from its source.